Goldman Sachs fumbles $143m Telix block trade, infuriating investors

The Australian Financial Review
02 Mar

What’s a good time to launch a block trade? According to Goldman Sachs’ equity capital markets team, the answer appears to be 11pm on a Thursday, and hours after a similarly sized sell-down at the same company.

That’s when the Wall Street investment banking giant decided to sell 1.5 per cent of Telix Pharmaceuticals, a Melbourne radiopharmaceuticals specialist with a market capitalisation of more than $9.5 billion, on behalf of China’s Grand Pharma. The next day, thanks to the ill-timed block trade, shares fell 6.3 per cent, wiping half a billion dollars from the company’s valuation.

Loading...

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10